Retinopathy of Prematurity research hub

An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

This study looks at how a medicine called aflibercept (Eylea) is used for premature babies in the UK who have an eye condition called Retinopathy of Prematurity (ROP). It's an information-gathering study to see how many babies are treated this way and to consider future research.